Surgery Partners Research and Development Expenses 2013-2024 | SGRY
Surgery Partners research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Surgery Partners Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| 2012 | $ |
| Surgery Partners Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2013-12-31 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.759B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.766B | 11.88 |
| Cencora (COR) | United States | $49.023B | 18.08 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| ICON (ICLR) | Ireland | $17.511B | 15.60 |
| Natera (NTRA) | United States | $16.712B | 0.00 |
| Viatris (VTRS) | United States | $15.433B | 4.75 |
| Avantor (AVTR) | United States | $14.831B | 22.24 |
| Revvity (RVTY) | United States | $14.647B | 25.44 |
| BioMerieux (BMXMF) | France | $12.894B | 0.00 |
| CochLear (CHEOY) | Australia | $12.739B | 0.00 |
| Solventum (SOLV) | United States | $12.214B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.215B | 31.59 |
| Charles River Laboratories (CRL) | United States | $11.042B | 21.34 |
| Doximity (DOCS) | United States | $10.778B | 63.79 |
| HealthEquity (HQY) | United States | $8.750B | 47.49 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.881B | 32.03 |
| Life Times (LTH) | United States | $5.005B | 33.12 |
| Sotera Health (SHC) | United States | $4.402B | 23.55 |
| Organon (OGN) | United States | $4.012B | 4.05 |
| BrightSpring Health Services (BTSG) | United States | $3.402B | 72.37 |
| PACS (PACS) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.579B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.523B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.446B | 0.00 |
| Premier (PINC) | United States | $2.301B | 11.48 |
| GeneDx Holdings (WGS) | United States | $2.113B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.783B | 47.00 |
| Teladoc Health (TDOC) | United States | $1.670B | 0.00 |
| Progyny (PGNY) | United States | $1.551B | 29.62 |
| Pediatrix Medical (MD) | United States | $1.331B | 13.02 |
| CareDx (CDNA) | United States | $1.251B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Embecta (EMBC) | United States | $0.898B | 5.99 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| InnovAge Holding (INNV) | United States | $0.778B | 0.00 |
| Agilon Health (AGL) | United States | $0.770B | 0.00 |
| SBC Medicals (SBC) | United States | $0.717B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| DocGo (DCGO) | United States | $0.426B | 16.00 |
| Enhabit (EHAB) | United States | $0.383B | 33.09 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.346B | 0.00 |
| LifeMD (LFMD) | United States | $0.310B | 0.00 |
| ModivCare (MODV) | United States | $0.244B | 13.24 |
| Sera Prognostics (SERA) | United States | $0.242B | 0.00 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Nutex Health (NUTX) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.204B | 0.00 |
| MultiPlan (MPLN) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
| So-Young (SY) | China | $0.073B | 17.77 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.12 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |